| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.28B | 14.62B | 13.73B | 13.25B | 13.20B |
| Gross Profit | 6.30B | 5.90B | 5.42B | 5.21B | 5.12B |
| EBITDA | 2.00B | 2.01B | 1.78B | 1.44B | 1.38B |
| Net Income | 1.20B | 1.12B | 976.34M | 1.08B | 1.10B |
Balance Sheet | |||||
| Total Assets | 13.43B | 12.89B | 12.40B | 13.32B | 13.01B |
| Cash, Cash Equivalents and Short-Term Investments | 1.71B | 1.25B | 979.35M | 1.69B | 2.04B |
| Total Debt | 1.76B | 2.11B | 2.84B | 3.86B | 3.84B |
| Total Liabilities | 6.47B | 6.53B | 6.65B | 8.11B | 8.29B |
| Stockholders Equity | 6.96B | 6.36B | 5.75B | 5.21B | 4.72B |
Cash Flow | |||||
| Free Cash Flow | 1.76B | 1.58B | 1.23B | 652.11M | -847.48M |
| Operating Cash Flow | 2.05B | 2.27B | 2.10B | 1.23B | -100.94M |
| Investing Cash Flow | -582.39M | -606.24M | -778.78M | -919.23M | -1.02B |
| Financing Cash Flow | -1.08B | -1.33B | -1.80B | -712.74M | 1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$32.56B | 9.88 | 14.66% | 3.32% | 16.15% | 17.32% | |
73 Outperform | HK$94.22B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
72 Outperform | HK$191.61B | 17.58 | 17.62% | 2.65% | 6.51% | 13.97% | |
72 Outperform | HK$61.07B | 7.92 | 11.78% | 5.34% | 3.68% | 7.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$81.81B | 12.43 | 7.45% | 7.28% | -3.92% | 2.33% | |
60 Neutral | HK$8.21B | 13.12 | 9.65% | 8.66% | 28.34% | ― |